Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 29

Results For "diagnostics"

452 News Found

Strand Life Sciences presents report on ‘Genomic Surveillance of SARS-CoV-2’
News | July 18, 2022

Strand Life Sciences presents report on ‘Genomic Surveillance of SARS-CoV-2’

Strand Life Sciences has sequenced a total of 12800 samples from July, 2021 to June, 2022, and identified more than a 100 lineages circulating in Bengaluru


MFine and LifeCell form JV ‘LifeWell’
Digitisation | July 11, 2022

MFine and LifeCell form JV ‘LifeWell’

LifeWell Raises USD 80M from OrbiMed to Build Large Scale Healthcare Delivery Platform with Full stack Diagnostics~


Boehringer Ingelheim, Evotec and bioMérieux forms JV Aurobac to fight antimicrobial resistance
News | July 06, 2022

Boehringer Ingelheim, Evotec and bioMérieux forms JV Aurobac to fight antimicrobial resistance

The JV is funded by Boehringer Ingelheim as lead investor with 30 million EUR and by Evotec and bioMérieux with 5 million EUR each.


Apollo Hospitals integrates cardiovascular risk tool with ConnectedLife digital wellness solutions
Healthcare | July 06, 2022

Apollo Hospitals integrates cardiovascular risk tool with ConnectedLife digital wellness solutions

The AICVD tool can predict the risk of cardiovascular disease.


Biosynth Carbosynth expands peptide offering with acquisition of Pepscan
News | July 01, 2022

Biosynth Carbosynth expands peptide offering with acquisition of Pepscan

Addition of Pepscan with its peptide discovery, lead optimization and GMP manufacturing capabilities provides end-to-end offering to Biosynth Carbosynth’s peptide customers.


NADMED brings first CE-marked NAD+ analysis kit to the market
Medical Device | June 30, 2022

NADMED brings first CE-marked NAD+ analysis kit to the market

NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites


CPC Scientific announces new California peptide API manufacturing facility
News | June 24, 2022

CPC Scientific announces new California peptide API manufacturing facility

The 41,000 sq ft facility will be utilized to manufacture clinical to commercial-grade peptide products for increased manufacturing capacity


Medix Biochemica acquires Bioresource Technology
News | June 21, 2022

Medix Biochemica acquires Bioresource Technology

Bioresource Technology's state of the art manufacturing facility in Weston, Florida


India welcomes TRIPS waiver deal at WTO
News | June 21, 2022

India welcomes TRIPS waiver deal at WTO

TRIPS waiver for five years agreed in the recently concluded WTO will help countries manufacture COVID vaccines to deal with the pandemic